News

A University of Utah biochemist found himself on Time Magazine's 100 most influential people of 2025 list alongside names ...
Biotech bigwig Gilead Sciences, Inc. GILD is scheduled to report first-quarter 2025 results on April 24, after market close.
The Trump administration's cuts to HIV prevention will lead to new infections, medical costs and death, experts warn.
During the first quarter, 22 rounds of biopharma layoffs in California affected about 995 employees total, while 17 rounds in ...
University of Utah biochemist called ‘Pioneer’ in magazine’s annual list of influencers that includes politicians, ...
A Southwest Airlines plane comes in for a landing at Salt Lake City International Airport on Saturday, Sept. 14, 2024.
At current levels, we believe GILD scores above BMY, buoyed by solid fundamentals, potential approval of lenacapavir for HIV ...
The EU and other Western governments need to step up their funding commitments to AIDS programmes or risk a reversal of progress on ending HIV as a public health emergency by 2030 — at least those are ...
Unitaid, a health innovation agency hosted by the World Health Organization (WHO), is known for pioneering access to high-impact health interventions in low- and middle-income countries.
Research in the Sundquist lab laid the foundations for the development of lenacapavir, a drug that prevents HIV infection ...